Drug intelligence / Profile preview

dictamnine

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Dictamnine is a natural furoquinoline alkaloid primarily isolated from the root bark of *Dictamnus dasycarpus* (Cortex Dictamni). It is being investigated for its potent anti-inflammatory and anti-asthmatic properties. The compound's mechanism of action involves the modulation of the **TGF-β/Smad2/3 signaling pathway**, which is a critical driver of airway remodeling and subepithelial fibrosis in chronic respiratory diseases. Preclinical studies in murine models of asthma have demonstrated that dictamnine significantly reduces airway hyperresponsiveness, suppresses the production of Th2 cytokines and mucin 5AC, and mitigates inflammatory cell infiltration. Furthermore, it helps maintain bronchial epithelial integrity by upregulating tight junction proteins such as ZO-1 and inhibiting the phosphorylation of Smad2/3.

Other names
Dic
02

Targets

MET (Mesenchymal-epithelial transition factor receptor)

Beyond the preview

Go deeper on dictamnine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dictamnine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call